Open access
Open access
Powered by Google Translator Translator

General Gynecology

M-A: Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy in BRCA1/2 pathogenic variant (PV) carriers.

22 Mar, 2022 | 07:58h | UTC

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis – Journal of Clinical Oncology

 

Multi-disciplinary care planning of ovarian cancer in older patients.

18 Mar, 2022 | 07:55h | UTC

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO – Cancers

 

Trends in HPV–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017.

17 Mar, 2022 | 08:16h | UTC

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 – JAMA Network Open

Author Interview: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations

Related:

[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

 

Systematic Review: Perioperative enhanced recovery programs for women with gynecological cancers.

16 Mar, 2022 | 10:05h | UTC

Perioperative enhanced recovery programmes for women with gynaecological cancers – Cochrane Library

See also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)

 

Management and care of patients with invasive cervical cancer: ASCO resource-stratified guideline rapid recommendation update.

14 Mar, 2022 | 00:40h | UTC

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update – JCO Global Oncology

News Release: ASCO Guideline Recommends Addition of Monoclonal Antibody to Invasive Cervical Cancer Management – ASCO Daily News

 

RCT: Methenamine Hippurate (a non-antibiotic preventive treatment) is noninferior to prophylactic antibiotics for treating recurrent urinary tract infections in women.

11 Mar, 2022 | 10:21h | UTC

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial – The BMJ

News Release: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom

Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ

Commentaries:

Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP

Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay

 

Commentary on Twitter

https://twitter.com/bmj_latest/status/1501800030608494596

 

Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.

3 Mar, 2022 | 08:14h | UTC

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology

Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge

 

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Related:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 

M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.

24 Feb, 2022 | 10:02h | UTC

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)

Related:

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.

 

RCT: Single-dose metronidazole vs. treatment for 7 days for treating Trichomonas vaginalis in women.

21 Feb, 2022 | 08:23h | UTC

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women – Sexually Transmitted Diseases (link to abstract – $ for full-text)

 

Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women.

18 Feb, 2022 | 08:44h | UTC

Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018 – The Lancet

News release: More than a quarter of women have experienced intimate partner violence in their lifetimes, finds new study – The Lancet

Commentary: Intimate partner violence against women: a persistent and urgent challenge – The Lancet

 

Commentary on Twitter (thread – click for more)

 

German Guidelines for the diagnosis, therapy and follow-up of cervical cancer – Part 1 with recommendations on epidemiology, screening, diagnostics and therapy.

17 Feb, 2022 | 08:47h | UTC

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy – Geburtshilfe und Frauenheilkunde

 

FIMS / EFSMA Joint position statement on the International Olympic Committee framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.

13 Feb, 2022 | 22:17h | UTC

Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations – BMJ Open Sport & Exercise Medicine

Original Guidance: IOC Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations – International Olympic Committee

Commentary: International Olympic Committee transgender guidance criticised by medical experts – BBC

 

Commentary on Twitter

 

Podcast: Chronic pelvic pain.

11 Feb, 2022 | 08:27h | UTC

Chronic Pelvic Pain – The Curbsiders

 

Summary: 2021 CDC guidelines on sexually transmitted infections.

7 Feb, 2022 | 08:33h | UTC

2021 CDC guidelines on sexually transmitted infections – Family Medicine

Original Guideline: CDC releases new guidelines for the treatment of sexually transmitted infections.

Related: WHO Guidelines for the management of symptomatic sexually transmitted infections.

 

ESSM Position Statement: Sexual Wellbeing After Gender Affirming Surgery.

4 Feb, 2022 | 08:34h | UTC

ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery” – Sexual Medicine

 

Review: Evaluation and management of vaginitis.

3 Feb, 2022 | 08:37h | UTC

Evaluation and Management of Vaginitis – Mayo Clinic Proceedings

 

Review: Behçet syndrome.

3 Feb, 2022 | 08:29h | UTC

Behçet syndrome – Nature Reviews Disease Primers (if the link is paywalled, try this one)

Infographic: Behçet syndrome (if the link is paywalled, try this one)

Related: EULAR recommendations for the management of Behçet’s syndrome

 

Editorial: Menstruation and Covid-19 vaccination.

2 Feb, 2022 | 08:46h | UTC

Menstruation and covid-19 vaccination – The BMJ

News Release: New studies provide reassuring data on menstrual changes after covid-19 vaccination – BMJ

 

Commentary on Twitter

 

Review: Primary care-based cardiovascular disease risk management after adverse pregnancy outcomes.

1 Feb, 2022 | 08:29h | UTC

Primary Care–Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review – Journal of General Internal Medicine (if the link is paywalled, try this one)

Commentary: Better management of long-term heart disease risk needed following complicated pregnancies – Boston Medical Center

See also: thread from the author on Twitter summarizing the article

Related:

A national cohort study in Sweden showed pregnancy complications (preeclampsia or eclampsia, gestational hypertension, gestational diabetes, preterm birth, small for gestational age, and stillbirth) are associated with increased risk of cardiovascular disease later in life.

AHA Scientific Statement | Adverse Pregnancy Outcomes and Cardiovascular Disease Risk

Consensus statement: Cardiovascular health after menopause transition, pregnancy disorders, and other gynecologic conditions

Cohort Study: Preeclampsia and Cardiovascular Disease

Cohort Study: Cardiovascular Disease After Hypertensive Disorders of Pregnancy Largely Explained by Conventional Cardiovascular Risk Factors (recent studies on the subject)

 

M-A: The diagnostic accuracy of syndromic management for genital ulcer disease.

1 Feb, 2022 | 08:12h | UTC

The Diagnostic Accuracy of Syndromic Management for Genital Ulcer Disease: A Systematic Review and Meta-Analysis – Frontiers in Medicine

 

Perspective: From vaginal laser treatment to spa breaks – it’s the great menopause gold rush.

27 Jan, 2022 | 09:36h | UTC

From vaginal laser treatment to spa breaks – it’s the great menopause gold rush – The Guardian

 

RCT: Single-dose 1000 mg ertapenem is non-inferior to single-dose 500 mg ceftriaxone for the treatment of gonorrhea.

25 Jan, 2022 | 09:20h | UTC

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)

 

Commentary on Twitter (thread – click for more)

 

RCT: Lactic acid gel vs. metronidazole for recurrent bacterial vaginosis in women aged 16 years and over.

24 Jan, 2022 | 08:13h | UTC

Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT – Health Technology Assessment

 

Practical Guide: Management of bladder pain syndrome.

24 Jan, 2022 | 07:52h | UTC

Management of Bladder Pain Syndrome (BPS): A Practical Guide – Advances in Urology

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.